Aquestive Therapeutics Inc

NAS:AQST (USA)  
$ 5.52 -0.58 (-9.52%) 11:09 PM EST
At Loss
Market Cap:
$ 404.62M
Enterprise V:
$ 455.85M
Volume:
2.56M
Avg Vol (2M):
1.93M
Volume:
2.56M
At Loss
Avg Vol (2M):
1.93M

Business Description

Aquestive Therapeutics Inc
NAICS : 325412 SIC : 2834
ISIN : US03843E1047
Description
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.72
Equity-to-Asset -1.86
Debt-to-Equity -0.31
Debt-to-EBITDA 28.19
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.8
Distress
Grey
Safe
Beneish M-Score -1.58
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 58.98
9-Day RSI 64.46
14-Day RSI 66.73
6-1 Month Momentum % 73.87
12-1 Month Momentum % 246.45

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.24
Quick Ratio 1.87
Cash Ratio 1.3
Days Inventory 114.1
Days Sales Outstanding 40.09
Days Payable 182.21

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -25.6
Shareholder Yield % 1

Financials (Next Earnings Date:2024-05-02 Est.)

AQST's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AQST

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Aquestive Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 50.583
EPS (TTM) ($) -0.154
Beta 1.69
Volatility % 112.09
14-Day RSI 66.73
14-Day ATR ($) 0.54871
20-Day SMA ($) 4.2135
12-1 Month Momentum % 246.45
52-Week Range ($) 0.77 - 6.23
Shares Outstanding (Mil) 73.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Aquestive Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Aquestive Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Aquestive Therapeutics Inc Frequently Asked Questions

What is Aquestive Therapeutics Inc(AQST)'s stock price today?
The current price of AQST is $5.52. The 52 week high of AQST is $6.23 and 52 week low is $0.77.
When is next earnings date of Aquestive Therapeutics Inc(AQST)?
The next earnings date of Aquestive Therapeutics Inc(AQST) is 2024-05-02 Est..
Does Aquestive Therapeutics Inc(AQST) pay dividends? If so, how much?
Aquestive Therapeutics Inc(AQST) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1